The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Official Title: A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Study ID: NCT01097018
Brief Summary: The trial will compare the overall survival of perifosine plus capecitabine to placebo plus capecitabine in patients with refractory advanced colorectal cancer.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, Alhambra, California, United States
, Bakersfield, California, United States
, La Verne, California, United States
, Long Beach, California, United States
, Los Angeles, California, United States
, Northridge, California, United States
, Redondo Beach, California, United States
, Santa Barbara, California, United States
, Santa Maria, California, United States
, Denver, Colorado, United States
, Grand Junction, Colorado, United States
Yale University School of Medicine, New Haven, Connecticut, United States
, Stamford, Connecticut, United States
, Waterbury, Connecticut, United States
, Fort Myers, Florida, United States
, Hollywood, Florida, United States
, Pembroke Pines, Florida, United States
, Athens, Georgia, United States
, Atlanta, Georgia, United States
, Lawrenceville, Georgia, United States
, Marietta, Georgia, United States
, Roswell, Georgia, United States
, Harvey, Illinois, United States
, Park Ridge, Illinois, United States
, South Bend, Indiana, United States
, Terre Haute, Indiana, United States
, Baltimore, Maryland, United States
, Bethesda, Maryland, United States
, Lansing, Michigan, United States
, Jackson, Mississippi, United States
, Tupelo, Mississippi, United States
, St. Louis, Missouri, United States
, Lincoln, Nebraska, United States
, Henderson, Nevada, United States
, Las Vegas, Nevada, United States
, Morristown, New Jersey, United States
, Albuquerque, New Mexico, United States
, Albuquerque, New Mexico, United States
, Armonk, New York, United States
, Great Neck, New York, United States
, New Hyde Park, New York, United States
, New York City, New York, United States
, Charlotte, North Carolina, United States
, Bismark, North Dakota, United States
, Fargo, North Dakota, United States
, Cincinnati, Ohio, United States
, Columbus, Ohio, United States
, Oklahoma City, Oklahoma, United States
, Columbia, South Carolina, United States
, Chattanooga, Tennessee, United States
, Memphis, Tennessee, United States
TN Oncology, Nashville, Tennessee, United States
, Abilene, Texas, United States
, Austin, Texas, United States
, Beaumont, Texas, United States
, Dallas, Texas, United States
, Dallas, Texas, United States
, Dallas, Texas, United States
, Fort Worth, Texas, United States
, Houston, Texas, United States
, Midland, Texas, United States
, Tyler, Texas, United States
, Richmond, Virginia, United States
, Seattle, Washington, United States
, Spokane, Washington, United States
Name: Johanna Bendell, MD
Affiliation: SCRI Development Innovations, LLC
Role: PRINCIPAL_INVESTIGATOR